1) H22 liver cancer
H22肝癌
1.
Enhancement of chemotherapeutic response of insulin on 5-fluorouracil in nude mice with transplanted H22 liver cancer
胰岛素联合5-氟尿嘧啶对H22肝癌移植瘤裸鼠的化疗增效作用
2.
Objective: To observe whether insulin can enhance the chemotherapeutic response of 5-fluorouracil(5-FU) in transplanted H22 liver cancer in nude mice and to investigate the underlying mechanism.
目的:建立裸鼠H22肝癌移植瘤模型,观察胰岛素是否增强5-氟脲嘧啶(5-FU)对裸鼠移植瘤的化疗疗效并探讨其机制。
3.
Methods:Transplanted tumor H22 liver cancer in mice were made,filling on 5‰CMC, high,moderate,low dosage .
目的：观察小柴胡汤及药群配伍对小鼠 H22肝癌实体瘤及免疫器官的影响,明确小柴胡汤抗肝肿瘤的作用及量效关系,探讨小柴胡汤及药群内在配伍意义。
2) H22 hepatoma
H22肝癌
1.
The Radiosensitizing Effects of Dihydrotanshinone Ⅰ on H22 Hepatoma-bearing Mices
二氢丹参酮Ⅰ对H22肝癌荷瘤小鼠的放射增敏作用
2.
RESULTS At the dose of 1,6 and 12 mg/kg,Polysaccharide from fermented Tremella fuciformis exhibit certain inhibition effect on U14 cervical cancer, H22 hepatoma and S180 sarcoma in mice.
目的:研究银耳孢子多糖对小鼠U14宫颈癌、H22肝癌、S180肉瘤的抑制作用。
3.
Objective:To study the synergistic effects of ethanol extracts from honeybee hives on the therapeutic efficacy of chemotherapy and radiotherapy to transplanted H22 hepatoma in mice.
目的:观察蜂房乙醇提取物对荷H22肝癌小鼠的放化疗增效作用。
3) H22 hepatocarcinoma
H22肝癌
1.
Objective:To investigate the dose-chemotactic effect relationship of secondary lymphoid tissue chemokine(SLC) eukaryotic expression plasmid and the dose-effect relationship of SLC plasmid on mouse H22 hepatocarcinoma.
目的:观察次级淋巴组织趋化因子(SLC)真核表达质粒剂量-趋化效应关系及不同剂量体内应用时对小鼠H22肝癌的治疗作用。
2.
Objective:To study the effect of Listeria DNA on expression of Bcl-2 in H22 hepatocarcinoma in mice,and to investigate the mechanism of the inhibition effect of Listeria DNA on H22 hepatocarcinoma.
目的:检测李斯特菌DNA对小鼠H22肝癌Bcl-2基因表达的影响,探讨细菌DNA对肿瘤的抑制作用。
4) H22 Hepatocellular Carcinoma Cells
肝癌H22
1.
Effects of E838 in Combination with γ-ray on H22 Hepatocellular Carcinoma Cells of Mice;
E838联合γ射线对小鼠肝癌H22抑瘤作用的实验研究
5) H22 liver cancer cell line
H22肝癌株
6) H22 hepatoma mice
肝癌H22小鼠
补充资料：(22E,24R)-麦角甾烷-5,7,22-三烯-3β醇
分子式：C28H44O
分子量：396.66
CAS号：57-87-4
性质：片状结晶（乙醇）或针状结晶（乙醚）。含1.5mol结晶水者，熔点168℃。沸点250℃/1.4Pa。[α]20/D-135°（C1.2，氯仿）。
制备方法：由从葡萄糖合成该品的酵母中提取。
用途：是生产维生素D2的前体，也是生产激素类药物的中间体，可用来生产可的松。
分子量：396.66
CAS号：57-87-4
性质：片状结晶（乙醇）或针状结晶（乙醚）。含1.5mol结晶水者，熔点168℃。沸点250℃/1.4Pa。[α]20/D-135°（C1.2，氯仿）。
制备方法：由从葡萄糖合成该品的酵母中提取。
用途：是生产维生素D2的前体，也是生产激素类药物的中间体，可用来生产可的松。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条